Susquehanna International Group
SKYE icon

Susquehanna International Group’s Skye Bioscience SKYE Stock Holding History

Susquehanna International Group’s Portfolio SKYE Stock Details SKYE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-22,900
Closed -$90K – 13852
2025
Q3 		$90K Sell
22,900
-500
-2% -$1.89K ﹤0.01% 11630
2025
Q2 		$97.8K Buy
23,400
+10,100
+76% +$20.9K ﹤0.01% 11810
2025
Q1 		$21.1K Buy
+13,300
New +$36.3K ﹤0.01% 12098

Other funds holding SKYE

5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return

Susquehanna International Group's SKYE Position: Q4 2025 in Review

Susquehanna International Group sold out of Skye Bioscience (SKYE) in Q4 2025, closing a stake of 28,735 shares — an estimated $113K sold.

Susquehanna International Group first reported a position in SKYE in Q3 2024 and held it in 5 quarters. The position peaked at $308K in Q2 2025. 50 funds tracked by Wall St. Rank hold SKYE as of Q4 2025.

  • Susquehanna International Group reported no remaining Skye Bioscience position as of Q4 2025 after selling out during the quarter.
  • Susquehanna International Group sold 28,735 Skye Bioscience shares in Q4 2025, an estimated $113K.
  • Susquehanna International Group first reported a position in Skye Bioscience in Q3 2024 and held it in 5 quarters.
  • Susquehanna International Group's Skye Bioscience position peaked at $308K in Q2 2025.
  • 50 funds tracked by Wall St. Rank held Skye Bioscience as of Q4 2025.

Based on Susquehanna International Group's 13F filing for Q4 2025, filed 17 Feb 2026.